Commodore Capital LP Diversified Active

CIK: 0001831942 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: Oct 14, 2021

Total Value ($000): $251,032 (100.0% shares, 0.0% debt)

Holdings (31)

ACRS ACLARIS THERAPEUTICS INC 10.3%

Value ($000) $25,908 Shares 1,028,084 Est. Cost $4.22 Unrealized +363.6%

CCCC C4 THERAPEUTICS INC 7.1%

Value ($000) $17,795 Shares 481,094 Est. Cost $29.00 Unrealized +37.2%

KURA KURA ONCOLOGY INC 5.9%

Value ($000) $14,744 Shares 521,555 Est. Cost $32.53 Unrealized -2.8%

— SATSUMA PHARMACEUTICALS INC 5.7%

Value ($000) $14,371 Shares 2,431,705 Est. Cost $5.91 Unrealized —

— FIVE PRIME THERAPEUTICS INC 5.4%

Value ($000) $13,612 Shares 361,344 Est. Cost $17.01 Unrealized —

— CYMABAY THERAPEUTICS INC 5.4%

Value ($000) $13,545 Shares 2,983,513 Est. Cost $5.14 Unrealized —

COGT COGENT BIOSCIENCES INC 4.4%

Value ($000) $11,144 Shares 1,269,195 Est. Cost $10.44 Unrealized -7.8%

— IVERIC BIO INC 4.3%

Value ($000) $10,685 Shares 1,729,041 Est. Cost $6.72 Unrealized —

PTGX PROTAGONIST THERAPEUTICS INC 3.6%

Value ($000) $9,055 Shares 349,600 Est. Cost $21.52 Unrealized +17.6%

— KRONOS BIO INC 3.5%

Value ($000) $8,747 Shares 298,839 Est. Cost $29.87 Unrealized —

— CONSTELLATION PHARMCETICLS I 3.4%

Value ($000) $8,618 Shares 368,448 Est. Cost $28.80 Unrealized —

— TRILLIUM THERAPEUTICS INC 3.4%

Value ($000) $8,548 Shares 795,868 Est. Cost $14.71 Unrealized —

— VISTAGEN THERAPEUTICS INC 3.2%

Value ($000) $7,944 Shares 3,729,694 Est. Cost $1.97 Unrealized —

GNCAQ GENOCEA BIOSCIENCES INC 3.1%

Value ($000) $7,782 Shares 2,871,624 Est. Cost $2.54 Unrealized +16.5%

CLDX CELLDEX THERAPEUTICS INC NEW 3.0%

Value ($000) $7,621 Shares 369,951 Est. Cost $18.18 Unrealized +26.3%

— MERSANA THERAPEUTICS INC 2.8%

Value ($000) $6,945 Shares 429,228 Est. Cost $20.04 Unrealized —

MREO MEREO BIOPHARMA GROUP PLC 2.8%

Value ($000) $6,904 Shares 2,048,757 Est. Cost $3.56 Unrealized —

DYN DYNE THERAPEUTICS INC 2.7%

Value ($000) $6,680 Shares 430,112 Est. Cost $19.35 Unrealized 0.0%

RLMD RELMADA THERAPEUTICS INC 2.3%

Value ($000) $5,689 Shares 161,565 Est. Cost $34.36 Unrealized +1.8%

KALV KALVISTA PHARMACEUTICALS INC 2.2%

Value ($000) $5,510 Shares 214,467 Est. Cost $26.28 Unrealized 0.0%

XENE XENON PHARMACEUTICALS INC 2.1%

Value ($000) $5,395 Shares 301,392 Est. Cost $11.70 Unrealized +44.9%

SNDX SYNDAX PHARMACEUTICALS INC 2.1%

Value ($000) $5,288 Shares 236,500 Est. Cost $20.74 Unrealized +8.9%

— ESSA PHARMA INC 2.0%

Value ($000) $5,137 Shares 176,821 Est. Cost $29.05 Unrealized —

SPRY SILVERBACK THERAPEUTICS INC 1.7%

Value ($000) $4,238 Shares 97,143 Est. Cost $33.40 Unrealized +41.7%

PMVP PMV PHARMACEUTICALS INC 1.6%

Value ($000) $4,111 Shares 125,000 Est. Cost $39.23 Unrealized +0.5%

IVA INVENTIVA SA 1.5%

Value ($000) $3,861 Shares 262,658 Est. Cost $14.53 Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 1.2%

Value ($000) $3,104 Shares 185,781 Est. Cost $18.72 Unrealized 0.0%

— SERES THERAPEUTICS INC 1.2%

Value ($000) $2,909 Shares 141,303 Est. Cost $20.59 Unrealized —

— BCLS ACQUISITION CORP 1.1%

Value ($000) $2,643 Shares 250,000 Est. Cost $11.14 Unrealized —

MGNX MACROGENICS INC 0.6%

Value ($000) $1,485 Shares 46,630 Est. Cost $24.28 Unrealized 0.0%

— LIFESCI ACQUISITION II CORP 0.4%

Value ($000) $1,014 Shares 100,000 Est. Cost $10.67 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ACRS	ACLARIS THERAPEUTICS INC	1,028,084	$25,908	10.3%	$4.22	+363.6%	COM	00461U105
CCCC	C4 THERAPEUTICS INC	481,094	$17,795	7.1%	$29.00	+37.2%	COM STK	12529R107
KURA	KURA ONCOLOGY INC	521,555	$14,744	5.9%	$32.53	-2.8%	COM	50127T109
—	SATSUMA PHARMACEUTICALS INC	2,431,705	$14,371	5.7%	$5.91	—	COM	80405P107
—	FIVE PRIME THERAPEUTICS INC	361,344	$13,612	5.4%	$17.01	—	COM	33830X104
—	CYMABAY THERAPEUTICS INC	2,983,513	$13,545	5.4%	$5.14	—	COM	23257D103
COGT	COGENT BIOSCIENCES INC	1,269,195	$11,144	4.4%	$10.44	-7.8%	COM	19240Q201
—	IVERIC BIO INC	1,729,041	$10,685	4.3%	$6.72	—	COM	46583P102
PTGX	PROTAGONIST THERAPEUTICS INC	349,600	$9,055	3.6%	$21.52	+17.6%	COM	74366E102
—	KRONOS BIO INC	298,839	$8,747	3.5%	$29.87	—	COM	50107A104
—	CONSTELLATION PHARMCETICLS I	368,448	$8,618	3.4%	$28.80	—	COM	210373106
—	TRILLIUM THERAPEUTICS INC	795,868	$8,548	3.4%	$14.71	—	COM NEW	89620X506
—	VISTAGEN THERAPEUTICS INC	3,729,694	$7,944	3.2%	$1.97	—	COM NEW	92840H202
GNCAQ	GENOCEA BIOSCIENCES INC	2,871,624	$7,782	3.1%	$2.54	+16.5%	COM NEW	372427401
CLDX	CELLDEX THERAPEUTICS INC NEW	369,951	$7,621	3.0%	$18.18	+26.3%	COM NEW	15117B202
—	MERSANA THERAPEUTICS INC	429,228	$6,945	2.8%	$20.04	—	COM	59045L106
MREO	MEREO BIOPHARMA GROUP PLC	2,048,757	$6,904	2.8%	$3.56	—	ADS	589492107
DYN	DYNE THERAPEUTICS INC	430,112	$6,680	2.7%	$19.35	0.0%	COM	26818M108
RLMD	RELMADA THERAPEUTICS INC	161,565	$5,689	2.3%	$34.36	+1.8%	COM	75955J402
KALV	KALVISTA PHARMACEUTICALS INC	214,467	$5,510	2.2%	$26.28	0.0%	COM	483497103
XENE	XENON PHARMACEUTICALS INC	301,392	$5,395	2.1%	$11.70	+44.9%	COM	98420N105
SNDX	SYNDAX PHARMACEUTICALS INC	236,500	$5,288	2.1%	$20.74	+8.9%	COM	87164F105
—	ESSA PHARMA INC	176,821	$5,137	2.0%	$29.05	—	COM NEW	29668H708
SPRY	SILVERBACK THERAPEUTICS INC	97,143	$4,238	1.7%	$33.40	+41.7%	COM	82835W108
PMVP	PMV PHARMACEUTICALS INC	125,000	$4,111	1.6%	$39.23	+0.5%	COM	69353Y103
IVA	INVENTIVA SA	262,658	$3,861	1.5%	$14.53	—	ADS	46124U107
VRDN	VIRIDIAN THERAPEUTICS INC	185,781	$3,104	1.2%	$18.72	0.0%	COM	92790C104
—	SERES THERAPEUTICS INC	141,303	$2,909	1.2%	$20.59	—	COM	81750R102
—	BCLS ACQUISITION CORP	250,000	$2,643	1.1%	$11.14	—	COM CL A	G0904B105
MGNX	MACROGENICS INC	46,630	$1,485	0.6%	$24.28	0.0%	COM	556099109
—	LIFESCI ACQUISITION II CORP	100,000	$1,014	0.4%	$10.67	—	COM	53229E103